Action Antibe Therapeutics - ATE

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

0,295

Prix Achat

0,09

Prix Vente

0,09

Volume échangé

0,00 Fourchette du Jour 0,00

0,15 Plage de 52 semaines 0,49

Clôture Veille

0,295

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Antibe Announces Appointment of Receiver

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE) announced that the Company’s request for an extension of its previously announced...

Antibe Provides Update on CCAA Proceedings

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE) announced that the Company sought an extension of its previously announced stay...

Antibe Announces TSX Delisting Review

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE) announced that the Toronto Stock Exchange (“TSX”) is reviewing the eligibility...

Antibe Announces Granting of Initial Order Under Companies' Creditors Arrangement Act

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE, OTCQX: ATBPF) announced that its previously announced application for an Initial...

Antibe to File an Application for an Initial Order Under Companies' Creditors Arrangement Act

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE, OTCQX: ATBPF) announced that it intends to file an application today with the...

Antibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance

Antibe Therapeutics Inc. (“Antibe” or the “Company” TSX: ATE, OTCQX: ATBPF) today announced that it received verbal notice on the afternoon of...

Antibe to Present Otenaproxesul PK/PD Results at the ASRA Pain Medicine Meeting

- The American Society of Regional Anesthesia and Pain Medicine is the largest subspecialty medical society in anesthesiology Antibe Therapeutics...

Antibe to Present Otenaproxesul PK/PD Results at the American Academy of Pain Medicine Meeting

- AAPM is the primary organization for pain medicine physicians in the U.S. Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage...

Antibe Announces Unfavorable Decision in Arbitration With Nuance Pharma

Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage biotechnology company leveraging its hydrogen sulfide platform to target pain...

Antibe Reports Q3 2024 Interim Financial and Operating Results

- Successful PK/PD study confirms liver safety, sets stage for upgraded Phase II trial launch next month - Phase II trial enhancements include...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0.295	0.295	0.295	0	0	CS
4	0	0	0.295	0.295	0.295	0	0	CS
12	0	0	0.295	0.295	0.295	0	0	CS
26	0	0	0.295	0.295	0.295	0	0	CS
52	-0.165	-35.8695652174	0.46	0.49	0.15	16562	0.24554167	CS
156	-0.455	-60.6666666667	0.75	1.23	0.15	32567	0.59552668	CS
260	-0.12	-28.9156626506	0.415	7.52	0.15	85467	1.85703391	CS

ATE - Frequently Asked Questions (FAQ)

What is the current Antibe Therapeutics share price?

The current share price of Antibe Therapeutics is $ 0,295

What is the 1 year trading range for Antibe Therapeutics share price?

Antibe Therapeutics has traded in the range of $ 0,15 to $ 0,49 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
KRNKarnalyte Resources Inc	$ 0,155 (34,78%)	61,81k
AUMNGolden Minerals Company	$ 0,175 (34,62%)	3,32k
TSATTelesat Corporation	$ 31,58 (26,42%)	38,92k
EDREndeavour Silver Corp	$ 6,51 (24,47%)	1,98M
AYAAya Gold & Silver Inc	$ 11,71 (15,60%)	1,62M
NCFNorthcliff Resources Ltd	$ 0,04 (-20,00%)	15k
GECGlobal Education Communities Corp	$ 0,185 (-15,91%)	115,01k
CNTCentury Global Commodities Corporation	$ 0,03 (-14,29%)	16k
SFDNXT Energy Solutions Inc	$ 0,27 (-14,29%)	8k
PBLPollard Banknote Ltd	$ 21,69 (-12,72%)	36,45k
CNQCanadian Natural Resources Ltd	$ 41,41 (1,22%)	17,87M
VRNVeren Inc	$ 8,46 (3,30%)	15,36M
WCPWhitecap Resources Inc	$ 8,28 (3,63%)	15,17M
MFCManulife Financial Corporation	$ 41,24 (0,07%)	11,97M
SUSuncor Energy Inc	$ 51,03 (-0,99%)	9,73M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Antibe Therapeutics Inc (ATE)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés